Market revenue in 2023 | USD 8.0 million |
Market revenue in 2030 | USD 25.7 million |
Growth rate | 18% (CAGR from 2023 to 2030) |
Largest segment | Services |
Fastest growing segment | Services |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Services, NGS Commercial Software |
Key market players worldwide | Bio-Rad Laboratories Inc, DNAnexus, Qiagen NV, DNAstar, Pacific Biosciences of California Inc, Eurofins Scientific SE, Illumina Inc, PierianDx, Agilent Technologies Inc, Roche Holding AG, Alphabet Inc Class A, Thermo Fisher Scientific Inc, Golden Helix, Scigenom Labs, Genuity Science, Fabric Genomics (formerly Omicia), Congenica, Precigen |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to next-generation sequencing data analysis market will help companies and investors design strategic landscapes.
Services was the largest segment with a revenue share of 53.75% in 2023. Horizon Databook has segmented the Mexico next-generation sequencing data analysis market based on services, ngs commercial software covering the revenue growth of each sub-segment from 2018 to 2030.
Growth of Mexico NGS data analysis market can majorly be attributed to the rising prevalence of cancer, growing business activities of international market players, and rising acceptance of genetic technologies in the country.
NGS is emerging as a valuable method for obtaining enhanced cancer diagnosis & treatment. Growing prevalence of cancer is likely to increase adoption of NSG platforms for its diagnosis, which is likely to boost growth of Mexico NGS data analysis market during the forecast period.
Furthermore, in September 2021, Illumina, Inc. expanded its business in Mexico. The company announced commencement of its new facility, México Productos de Biotecnología, with an aim to consolidate offerings of genome technologies in the country. Such advancements are also expected to positively impact market growth.
Horizon Databook provides a detailed overview of country-level data and insights on the Mexico next-generation sequencing data analysis market , including forecasts for subscribers. This country databook contains high-level insights into Mexico next-generation sequencing data analysis market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account